Skip to Main Content

Author Details

Matthew Meyerson
Broad Institute
1983
386
163
PMIDPaper TitleJournal TitlePublished Year
36302897Velcrin-induced selective cleavage of tRNA<sup>Leu</sup>(TAA) by SLFN12 causes cancer cell death.Nat Chem Biol2023
36302897Velcrin-induced selective cleavage of tRNA<sup>Leu</sup>(TAA) by SLFN12 causes cancer cell death.Nat Chem Biol2023
37596911Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors.Pediatr Blood Cancer2023
37577567XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells.bioRxiv2023
37463056Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer.Clin Cancer Res2023
37461636Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation.bioRxiv2023
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
36747644Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.bioRxiv2023
36694348Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.Neuro Oncol2023
37380777Cancer aneuploidies are shaped primarily by effects on tumour fitness.Nature2023
37247843Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.J Thorac Oncol2023
36542958Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.Bioorg Med Chem2023
36542814Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069".J Med Chem2023
37045956Molecular portraits of lung cancer evolution.Nature2023
37596911Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors.Pediatr Blood Cancer2023
37577567XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells.bioRxiv2023
37247843Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.J Thorac Oncol2023
37045956Molecular portraits of lung cancer evolution.Nature2023
37380777Cancer aneuploidies are shaped primarily by effects on tumour fitness.Nature2023
37463056Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer.Clin Cancer Res2023
37461636Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation.bioRxiv2023
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
36694348Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.Neuro Oncol2023
36747644Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.bioRxiv2023
36542958Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.Bioorg Med Chem2023
36542814Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069".J Med Chem2023
35243413Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.Cell Rep Med2022
35395071Functional Genomic Analysis of CDK4 and CDK6 Gene Dependency across Human Cancer Cell Lines.Cancer Res2022
36245243Fusobacterium and Colorectal Cancer: Important Association or Random Coincidence?Cancer Res2022
36040167Tangent normalization for somatic copy-number inference in cancer genome analysis.Bioinformatics2022
35837755An international report on bacterial communities in esophageal squamous cell carcinoma.Int J Cancer2022
36028900Identifying and correcting repeat-calling errors in nanopore sequencing of telomeres.Genome Biol2022
35943799Patterns of structural variation define prostate cancer across disease states.JCI Insight2022
35872166Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer.Ann Oncol2022
36270630Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists <b>BAY-4931</b> and <b>BAY-0069</b>.J Med Chem2022
35418694Correction to: Oncogenic RIT1 mutations in lung adenocarcinoma.Oncogene2022
35365656Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.Nat Commun2022
35363834Long-read sequencing reveals complex patterns of wraparound transcription in polyomaviruses.PLoS Pathog2022
35922826Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.Genome Med2022
35919992Correction: Functional Genomic Analysis of CDK4 and CDK6 Gene Dependency across Human Cancer Cell Lines.Cancer Res2022
35243413Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.Cell Rep Med2022
35837755An international report on bacterial communities in esophageal squamous cell carcinoma.Int J Cancer2022
35395071Functional Genomic Analysis of CDK4 and CDK6 Gene Dependency across Human Cancer Cell Lines.Cancer Res2022
35365656Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.Nat Commun2022
35363834Long-read sequencing reveals complex patterns of wraparound transcription in polyomaviruses.PLoS Pathog2022
35418694Correction to: Oncogenic RIT1 mutations in lung adenocarcinoma.Oncogene2022
35872166Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer.Ann Oncol2022
36245243Fusobacterium and Colorectal Cancer: Important Association or Random Coincidence?Cancer Res2022
36040167Tangent normalization for somatic copy-number inference in cancer genome analysis.Bioinformatics2022
36270630Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists <b>BAY-4931</b> and <b>BAY-0069</b>.J Med Chem2022
  • 1 - 50 of 772

Recommended Authors

Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 30
Larissa A Pikor
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 6
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 2
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 14
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 39
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 13
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 52
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 19
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 41
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 56
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 12
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 12
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 34
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 14
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 36
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 39
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 5
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 6
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 14
Adam Butler
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 62
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 43
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 15
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 3
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 22
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 100
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 106
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 31
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 30

Collaborators

Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 85
Rameen Beroukhim
Co-authored papers 60
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 49
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 48
Stacey Gabriel
Broad Institute of MIT and Harvard
Co-authored papers 45
Michael S Lawrence
Co-authored papers 42
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 41
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 39
Eric S Lander
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 39
Chandra Sekhar Pedamallu
Broad Institute
Co-authored papers 37
William R Sellers
Co-authored papers 34
Kristian Cibulskis
Co-authored papers 33
Pasi A J??nne
Dana-Farber Cancer Institute
Co-authored papers 32
Scott L Carter
Co-authored papers 30
Carrie Sougnez
The Broad Institute of Harvard and MIT
Co-authored papers 29
Barbara A Weir
Janssen Research and Development LLC
Co-authored papers 28
Alex H Ramos
Co-authored papers 24
Wendy Winckler
Co-authored papers 24
Joshua M Francis
Co-authored papers 23
Adam J Bass
Co-authored papers 22
Robert C Onofrio
The Broad Institute of Harvard and MIT
Co-authored papers 21
Aaron R Thorner
Co-authored papers 21
Andrey Sivachenko
Cystic Fibrosis Foundation
Co-authored papers 21
Mark A Rubin
University of Bern
Co-authored papers 21
Craig H Mermel
Co-authored papers 21
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 19
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 19
Peter S Hammerman
Novartis Institutes for BioMedical Research
Co-authored papers 18
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 18
Chip Stewart
Broad Institute of MIT and Harvard
Co-authored papers 17
Release 1.2